| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
From the Departments of Pathology
(Neuropathology)*
and
Microbiology,
University of Virginia School of
Medicine, Charlottesville, Virginia
Abnormal growth factor signaling is implicated in the pathogenesis of gliomas. The extracellular signal-regulated kinase (ERK)/mitogen-activated protein kinase (MAPK) pathway is a likely target, linking receptor tyrosine kinase activation to downstream serine/threonine phosphorylation events regulating proliferation and differentiation. Signaling within heterogeneous cell populations of gliomas cannot be adequately assessed by traditional biochemical enzyme assays. Immunohistochemical detection of doubly phosphorylated (activated) ERK/MAPK permitted visualization of spatially discrete cellular patterns of ERK/MAPK activation, compared with the relatively uniform expression of total ERK/MAPK protein. The astrocytic tumors, regardless of grade, had the highest overall degree of enzyme activation, whereas oligodendrogliomas had the least. Anaplastic progression in oligodendrogliomas resulted in a larger number of cells with active ERK/MAPK. Within glioblastomas, microvascular hyperplasia and necrosis were associated with ERK/MAPK activation in adjacent tumor cells. In addition to spatial patterns of intratumor paracrine signaling, a possible cell-cycle-associated regulation was detected: mitotic and actively cycling tumor cells showed diminished activation relative to cells in G0. Although ERK/MAPK activation was not restricted to neoplastic glia, consistent patterns of selective activation in tumor cells suggests that sustained activation may contribute to the neoplastic glial phenotype.
This article has been cited by other articles:
 |
|
 |
|
  D. Huang, Y. Ding, W.-M. Luo, S. Bender, C.-N. Qian, E. Kort, Z.-F. Zhang, K. VandenBeldt, N. S. Duesbery, J. H. Resau, et al. Inhibition of MAPK Kinase Signaling Pathways Suppressed Renal Cell Carcinoma Growth and Angiogenesis In vivo Cancer Res., January 1, 2008; 68(1): 81 - 88. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Mangiola, G. Lama, C. Giannitelli, P. De Bonis, C. Anile, L. Lauriola, G. La Torre, G. Sabatino, G. Maira, M. Jhanwar-Uniyal, et al. Stem Cell Marker Nestin and c-Jun NH2-Terminal Kinases in Tumor and Peritumor Areas of Glioblastoma Multiforme: Possible Prognostic Implications Clin. Cancer Res., December 1, 2007; 13(23): 6970 - 6977. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. de Melo, M. W. Gerbase, J. Curran, and J.-C. Pache Phosphorylated Extracellular Signal-regulated Kinases Are Significantly Increased in Malignant Mesothelioma J. Histochem. Cytochem., August 1, 2006; 54(8): 855 - 861. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Gioeli, B. E. Black, V. Gordon, A. Spencer, C. T. Kesler, S. T. Eblen, B. M. Paschal, and M. J. Weber Stress Kinase Signaling Regulates Androgen Receptor Phosphorylation, Transcription, and Localization Mol. Endocrinol., March 1, 2006; 20(3): 503 - 515. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Kobel, G. Pohl, W. D. Schmitt, S. Hauptmann, T.-L. Wang, and I.-M. Shih Activation of Mitogen-Activated Protein Kinase Is Required for Migration and Invasion of Placental Site Trophoblastic Tumor Am. J. Pathol., September 1, 2005; 167(3): 879 - 885. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. W. Mandell Phosphorylation State-Specific Antibodies: Applications in Investigative and Diagnostic Pathology Am. J. Pathol., November 1, 2003; 163(5): 1687 - 1698. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Jorgensen, R. Holm, G. M. Maelandsmo, and V. A. Florenes Expression of Activated Extracellular Signal-Regulated Kinases 1/2 in Malignant Melanomas: Relationship with Clinical Outcome Clin. Cancer Res., November 1, 2003; 9(14): 5325 - 5331. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. MacKeigan, C. M. Clements, J. D. Lich, R. M. Pope, Y. Hod, and J. P-Y. Ting Proteomic Profiling Drug-Induced Apoptosis in Non-Small Cell Lung Carcinoma: Identification of RS/DJ-1 and RhoGDI{alpha} Cancer Res., October 15, 2003; 63(20): 6928 - 6934. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Clark, L. Zhong, D. Filiault, S. Perman, Z. Ren, M. Gould, and X. Yang Anti-Leukemia Effect of Perillyl Alcohol in Bcr/Abl-Transformed Cells Indirectly Inhibits Signaling through Mek in a Ras- and Raf-Independent Fashion Clin. Cancer Res., October 1, 2003; 9(12): 4494 - 4504. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Handra-Luca, H. Bilal, J.-C. Bertrand, and P. Fouret Extra-Cellular Signal-Regulated ERK-1/ERK-2 Pathway Activation in Human Salivary Gland Mucoepidermoid Carcinoma: Association to Aggressive Tumor Behavior and Tumor Cell Proliferation Am. J. Pathol., September 1, 2003; 163(3): 957 - 967. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Govindarajan, M. C. Mizesko, M. S. Miller, H. Onda, M. Nunnelly, K. Casper, D. Brat, C. Cohen, and J. L Arbiser Tuberous Sclerosis-associated Neoplasms Express Activated p42/44 Mitogen-activated Protein (MAP) Kinase, and Inhibition of MAP Kinase Signaling Results in Decreased in Vivo Tumor Growth Clin. Cancer Res., August 1, 2003; 9(9): 3469 - 3475. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Zhong, K. Jiang, D. L. Gilvary, P. K. Epling-Burnette, C. Ritchey, J. Liu, R. J. Jackson, E. Hong-Geller, and S. Wei Human neutrophils utilize a Rac/Cdc42-dependent MAPK pathway to direct intracellular granule mobilization toward ingested microbial pathogens Blood, April 15, 2003; 101(8): 3240 - 3248. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Govindarajan, X. Bai, C. Cohen, H. Zhong, S. Kilroy, G. Louis, M. Moses, and J. L Arbiser Malignant Transformation of Melanocytes to Melanoma by Constitutive Activation of Mitogen-activated Protein Kinase Kinase (MAPKK) Signaling J. Biol. Chem., March 7, 2003; 278(11): 9790 - 9795. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Tsuiki, M. Tnani, I. Okamoto, L. C. Kenyon, D. R. Emlet, M. Holgado-Madruga, I. S. Lanham, C. J. Joynes, K. T. Vo, and A. J. Wong Constitutively Active Forms of c-Jun NH2-terminal Kinase Are Expressed in Primary Glial Tumors Cancer Res., January 1, 2003; 63(1): 250 - 255. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Milanini-Mongiat, J. Pouyssegur, and G. Pages Identification of Two Sp1 Phosphorylation Sites for p42/p44 Mitogen-activated Protein Kinases. THEIR IMPLICATION IN VASCULAR ENDOTHELIAL GROWTH FACTOR GENE TRANSCRIPTION J. Biol. Chem., May 31, 2002; 277(23): 20631 - 20639. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-M. Koo, M. VanBrocklin, M. J. McWilliams, S. H. Leppla, N. S. Duesbery, and G. F. Vande Woude Apoptosis and melanogenesis in human melanoma cells induced by anthrax lethal factor inactivation of mitogen-activated protein kinase kinase PNAS, February 20, 2002; (2002) 52707699. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Albanell, J. Codony-Servat, F. Rojo, J. M. Del Campo, S. Sauleda, J. Anido, G. Raspall, J. Giralt, J. Rosello, R. I. Nicholson, et al. Activated Extracellular Signal-regulated Kinases: Association with Epidermal Growth Factor Receptor/Transforming Growth Factor {alpha} Expression in Head and Neck Squamous Carcinoma and Inhibition by Anti-Epidermal Growth Factor Receptor Treatments Cancer Res., September 1, 2001; 61(17): 6500 - 6510. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Buder-Hoffmann, C. Palmer, P. Vacek, D. Taatjes, and B. Mossman Different Accumulation of Activated Extracellular Signal-Regulated Kinases (ERK 1/2) and Role in Cell-Cycle Alterations by Epidermal Growth Factor, Hydrogen Peroxide, or Asbestos in Pulmonary Epithelial Cells Am. J. Respir. Cell Mol. Biol., April 1, 2001; 24(4): 405 - 413. [Abstract] [Full Text]
|
|
|
|
|
|
N. S. Duesbery, J. Resau, C. P. Webb, S. Koochekpour, H.-M. Koo, S. H. Leppla, and G. F. Vande Woude Suppression of ras-mediated transformation and inhibition of tumor growth and angiogenesis by anthrax lethal factor, a proteolytic inhibitor of multiple MEK pathways PNAS, March 16, 2001; (2001) 61031898. [Abstract] [Full Text]
|
|
|
|
|
|
R. F. Robledo, S. A. Buder-Hoffmann, A. B. Cummins, E. S. Walsh, D. J. Taatjes, and B. T. Mossman Increased Phosphorylated Extracellular Signal-Regulated Kinase Immunoreactivity Associated with Proliferative and Morphologic Lung Alterations after Chrysotile Asbestos Inhalation in Mice Am. J. Pathol., April 1, 2000; 156(4): 1307 - 1316. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Shinohara, H. Yagita, Y. Ikawa, and N. Oyaizu Fas Drives Cell Cycle Progression in Glioma Cells via Extracellular Signal-regulated Kinase Activation Cancer Res., March 1, 2000; 60(6): 1766 - 1772. [Abstract] [Full Text]
|
|
|
|
 |
|
 W.-S. Shim, M. Conaway, S. Masamura, W. Yue, J.-P. Wang, R. Kumar, and R. J. Santen Estradiol Hypersensitivity and Mitogen-Activated Protein Kinase Expression in Long-Term Estrogen Deprived Human Breast Cancer Cells in Vivo Endocrinology, January 1, 2000; 141(1): 396 - 405. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Gioeli, J. W. Mandell, G. R. Petroni, H. F. Frierson Jr., and M. J. Weber Activation of Mitogen-Activated Protein Kinase Associated with Prostate Cancer Progression Cancer Res., January 1, 1999; 59(2): 279 - 284. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. MacKeigan, T. S. Collins, and J. P.-Y. Ting MEK Inhibition Enhances Paclitaxel-induced Tumor Apoptosis J. Biol. Chem., December 8, 2000; 275(50): 38953 - 38956. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-M. Koo, M. VanBrocklin, M. J. McWilliams, S. H. Leppla, N. S. Duesbery, and G. F. V. Woude Apoptosis and melanogenesis in human melanoma cells induced by anthrax lethal factor inactivation of mitogen-activated protein kinase kinase PNAS, March 5, 2002; 99(5): 3052 - 3057. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. S. Duesbery, J. Resau, C. P. Webb, S. Koochekpour, H.-M. Koo, S. H. Leppla, and G. F. Vande Woude Suppression of ras-mediated transformation and inhibition of tumor growth and angiogenesis by anthrax lethal factor, a proteolytic inhibitor of multiple MEK pathways PNAS, March 27, 2001; 98(7): 4089 - 4094. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
